AbbVie has submitted a new drug application to the U.S. Food and Drug Administration (FDA) for ABBV-951 (foscarbidopa/foslevodopa), its…
Articles by Margarida Maia, PhD
A research grant from The Michael J. Fox Foundation (MJFF) will allow Asceneuron to advance work on ASN51, a…
Gb Sciences is initiating a dose-ranging study of its investigational cannabinoid-based formulations in a rodent model of Parkinson’s…
A just-launched wellness program is offering a two-week, inpatient rehabilitation experience tailored to the needs of people with Parkinson’s…
Inhibikase expects to begin a Phase 2a study of IkT-148009, its investigational therapy for Parkinson’s disease, in the…
Treatment with the low-dose painkiller ketamine eased levodopa-induced dyskinesia (uncontrollable body movements) in patients with Parkinson’s disease, according to results…
SQZ Biotechnologies has received a $2 million grant to work out a way to turn a patient’s own immune…
A form of the alpha-synuclein protein that can build up in the skin could help distinguish Parkinson’s disease from…
Excessive sweating, known as hyperhidrosis, is fairly common among people with Parkinson’s and can worsen as the disease progresses,…
Machine learning — a form of artificial intelligence that allows a computer to adapt, analyze, and infer from patterns in…